Molecular docking is an approach to drug design by characterizing the receptor and the mode of interaction between the receptor and the drug molecule. It is a theoretical modeling method that focuses on the study of intermolecular (e.g., ligand-receptor) interactions and the prediction of their binding modes and affinities. At CD ComputaBio, we offer a full suite of molecular docking services tailored to meet the diverse needs of our clients. Our expertise allows us to assist in the virtual screening, lead optimization, and drug design process, ultimately accelerating the drug discovery process. https://cadd.computabio.co...

Only people mentioned by VivianSmith in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Vivian Smith, click on at the bottom under it